Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.670
+0.050 (3.09%)
At close: Dec 5, 2025, 4:00 PM EST
1.650
-0.020 (-1.20%)
After-hours: Dec 5, 2025, 7:06 PM EST
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $118.92 million as of December 5, 2025. Its market cap has increased by 62.69% in one year.
Market Cap
118.92M
Enterprise Value
107.08M
1-Year Change
62.69%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $118.92M, a decrease of -60.54%. That is a compound annual growth rate of -10.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 118.90M | 79.34% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |